Malignant melanoma and Abnormal behavior

Summary:

Abnormal behavior is found among people with Malignant melanoma, especially for people who are male, 60+ old.

The study analyzes which people have Abnormal behavior with Malignant melanoma. It is created by eHealthMe based on reports of 21 people who have Malignant melanoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Malignant melanoma?

Malignant melanoma (skin cancer rises from melancytes) is found to be associated with 789 drugs and 740 conditions by eHealthMe. Check the latest studies of Malignant melanoma.

What is Abnormal behavior?

Abnormal behavior is found to be associated with 1,365 drugs and 1,948 conditions by eHealthMe. Check the latest studies of Abnormal behavior.



On Jul, 12, 2026

21 people who have Malignant Melanoma and Abnormal Behavior are studied.

Would you have Abnormal behavior when you have Malignant melanoma?

Gender of people who have Malignant Melanoma and experienced Abnormal Behavior *:

  • female: 28.57 %
  • male: 71.43 %

Age of people who have Malignant Melanoma and experienced Abnormal Behavior *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 5.88 %
  • 30-39: 23.53 %
  • 40-49: 5.88 %
  • 50-59: 5.88 %
  • 60+: 58.82 %

Common co-existing conditions for these people *:

  1. Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 9.52%
  2. Stress And Anxiety: 1 person, 4.76%
  3. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 4.76%
  4. Quit Smoking: 1 person, 4.76%
  5. Nausea (feeling of having an urge to vomit): 1 person, 4.76%
  6. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 4.76%
  7. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 4.76%
  8. Joint Pain: 1 person, 4.76%
  9. Depression: 1 person, 4.76%
  10. Breast Cancer: 1 person, 4.76%

Common drugs taken by these people *:

  1. Yervoy: 4 people, 19.05%
  2. Keytruda: 4 people, 19.05%
  3. Zelboraf: 4 people, 19.05%
  4. Aldactone: 3 people, 14.29%
  5. Tylenol: 2 people, 9.52%
  6. Amlodipine: 2 people, 9.52%
  7. Tafinlar: 2 people, 9.52%
  8. Lyrica: 2 people, 9.52%
  9. Morphine: 2 people, 9.52%
  10. Zoledronic Acid: 1 person, 4.76%

Common symptoms for these people *:

  1. Fever: 6 people, 28.57%
  2. Memory Loss: 5 people, 23.81%
  3. Headache (pain in head): 4 people, 19.05%
  4. Fatigue (feeling of tiredness): 4 people, 19.05%
  5. Nausea (feeling of having an urge to vomit): 4 people, 19.05%
  6. Confusional State: 4 people, 19.05%
  7. Depression: 3 people, 14.29%
  8. Dyspnea (difficult or laboured breathing): 3 people, 14.29%
  9. Hypoaesthesia (reduced sense of touch or sensation): 3 people, 14.29%
  10. Diarrhea: 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Abnormal behavior?

- Check whether Abnormal behavior is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Abnormal behavior:

All the conditions that are associated with Abnormal behavior:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Abnormal behavior and Malignant melanoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: